The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 24, 2022

Filed:

Nov. 28, 2018
Applicant:

The University of Vermont and State Agricultural College, Burlington, VT (US);

Inventors:

Christopher Francklyn, Burlington, VT (US);

Karen M. Lounsbury, Essex Junction, VT (US);

Tamara Williams, South Burlington, VT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/573 (2006.01); C12Q 1/25 (2006.01); C12Q 1/6883 (2018.01); C12Q 1/6886 (2018.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
G01N 33/573 (2013.01); C12Q 1/25 (2013.01); C12Q 1/6883 (2013.01); C12Q 1/6886 (2013.01); G01N 33/57496 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/9015 (2013.01); G01N 2800/52 (2013.01); G01N 2800/7014 (2013.01);
Abstract

The invention includes, in part, methods and compounds for diagnosing diseases and conditions characterized by altered threonyl-tRNA synthetase (TARS) activity, which include, but are not limited to diseases and conditions in which angiogenesis is altered. In some embodiments of the invention, a level of a TARS molecule is determined and compared to a control level of TARS to assess onset, progression, and/or regression of a disease or condition associated with altered TARS activity.


Find Patent Forward Citations

Loading…